As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.
20 Analysts have issued a Galderma forecast:
20 Analysts have issued a Galderma forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | 3,698 3,698 |
-
|
|
| Gross Profit | 2,560 2,560 |
-
|
|
| EBITDA | 839 839 |
-
|
|
| EBIT (Operating Income) EBIT | 595 595 |
-
|
|
| Net Profit | 298 298 |
-
|
|
In millions CHF.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland.
| Head office | Switzerland |
| CEO | Flemming Ørnskov |
| Website | www.galderma.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


